SEASTAR MEDICAL HOLDING CORPORATION - COMMON STOCK

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

08 4月 2025 08:05:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

27 3月 2025 16:05:00 条件 Nasdaq GlobeNewswire

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

24 3月 2025 17:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

03 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

31 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

27 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

22 1月 2025 07:30:00 条件 Nasdaq GlobeNewswire

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

13 1月 2025 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

08 1月 2025 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

23 12月 2024 07:00:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

11 12月 2024 06:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

04 12月 2024 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

03 12月 2024 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

26 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

22 11月 2024 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

15 11月 2024 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update

13 11月 2024 17:05:22 条件 Nasdaq GlobeNewswire

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

06 11月 2024 09:00:00 条件 Nasdaq GlobeNewswire

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

01 11月 2024 08:30:00 条件 Nasdaq GlobeNewswire

SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE

31 10月 2024 08:30:00 条件 Nasdaq GlobeNewswire